ATF3 and ischemic stroke: Our preclinical findings, which showed that ATF3 is elevated in mouse blood after SCI and ischaemic stroke, prompted us to investigate if serum ATF3 could serve as a biomarker for clinical patients with SCI or ischaemic stroke.